XML 18 R4.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Net sales $ 81,712 $ 67,689 $ 234,645 $ 193,466
Cost of sales 14,790 12,188 40,792 33,947
Gross profit 66,922 55,501 193,853 159,519
Operating expenses:        
Selling, general and administrative 52,571 53,475 156,773 158,838
Research and development 3,175 5,953 18,168 17,429
Restructuring (Note 16) 208 0 3,464 0
Investigation, restatement and related (38) 3,001 4,652 8,771
Amortization of intangible assets 190 175 570 519
Operating income (loss) 10,816 (7,103) 10,226 (26,038)
Other expense, net        
Interest expense, net (1,680) (1,270) (4,864) (3,566)
Other expense, net (11) 0 (42) (1)
Income (loss) before income tax provision 9,125 (8,373) 5,320 (29,605)
Income tax provision expense (591) (53) (569) (178)
Net income (loss) 8,534 (8,426) 4,751 (29,783)
Net income (loss) available to common shareholders (Note 9) $ 6,761 $ (10,096) $ (433) $ (34,667)
Net income (loss) per common share - basic (in dollars per share) $ 0.06 $ (0.09) $ (0.00) $ (0.31)
Net income (loss) per common share - diluted (in dollars per share) $ 0.06 $ (0.09) $ (0.00) $ (0.31)
Weighted average common shares outstanding - basic (in shares) 116,298,146 113,448,251 115,528,067 112,650,713
Weighted average common shares outstanding - diluted (in shares) 119,327,709 113,448,251 115,528,067 112,650,713